Category: Pharma & drug development
Peptomyc: the quest for a universal cancer treatment
What does ‘ageing’ mean when it comes to drug development?
Sky high: should US drugs prices fall in line with the rest of the world?
The rise of fake medicines in Africa
Q&A: Gavi alliance talks immunising 300 million people
Recurrent miscarriage: could this devastating condition have a simple cure?
A safer ride: the latest innovation in targeted cancer treatment
The problem of manipulated data
Why is pharma so bad at sharing clinical trial information?
Q&A: an eye on innovation with SparingVision
From start-ups to the SIX Swiss Exchange – a Swiss success story
ConcePTION: tackling the unknowns of medication in pregnancy
Understanding drug-resistant TB
How do cancer cells communicate and can it help us catch them?
Proteomics and the promise of ‘enriching’ clinical trials
Is growth factor protein the future of Parkinson’s treatment?
The drugs fighting memory loss
Medical cannabis in the UK: how has the roll out gone so far?
